Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenlong Jianji
- Development stage
- Phase 2
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shenlong Jianji (Chinese name: 参龙煎剂颗粒) is a traditional Chinese medicine (TCM) compound granule formulation. It is composed of multiple herbal ingredients including Codonopsis pilosula (党参), Asparagus cochinchinensis (天冬), Dioscorea opposita (山药), Prunus persica seed (桃仁), Curcuma longa (姜黄), Poria cocos (茯苓), Cinnamomum cassia twig (桂枝), Citrus reticulata segment membrane (橘络), Lumbricus terrestris dried body ("earthworm", 地龙), and Polygonum multiflorum stem (首乌藤). The preparation involves decocting these herbs, concentrating the extract, and spray-drying to form granules. Shenlong Jianji is primarily used for the treatment of idiopathic pulmonary fibrosis during remission periods in TCM practice. Its mechanism of action is based on the synergistic effects of its herbal components, which are believed in TCM theory to tonify Qi, nourish Yin, promote blood circulation, resolve stasis, and relieve symptoms associated with lung fibrosis[1]. Modern pharmacological mechanisms have not been fully elucidated; its effects are attributed to multi-target modulation typical for complex herbal formulas.
- Brand names
- Shenlong Jianji参龙煎剂颗粒
- Other names
- 参龙煎剂颗粒
Beyond the preview
Go deeper on Shenlong Jianji.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenlong Jianji.